stockrowTransMedics Group, Inc.
TMDX Healthcare Medical Devices
TransMedics Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $605.5 million, up 37.1% from fiscal 2024.
- Revenue
- +41.2%
- EPS
- −31.0%
- Free cash flow
- −55.4%
- Total debt
- −89.3%
Quarter to September 2026, against a year earlier
Follow TMDX
Alert me
TransMedics Group, Inc. (TMDX) Gross margin
TransMedics Group, Inc.'s gross margin over the twelve months to 30 September 2026 was 58.6%, down 1.3 percentage points from fiscal 2025 (59.9%). Over the past ten years it has ranged from 8.70% (fiscal 2016) to 69.9% (fiscal 2021); the current reading is higher than 60% of that period. That is in line with the Medical Devices industry median of 57.8% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 59.9% | 0.56 |
| FY2024 | 59.4% | (4.41) |
| FY2023 | 63.8% | (6.07) |
| FY2022 | 69.8% | (0.08) |
| FY2021 | 69.9% | 5.04 |
| FY2020 | 64.9% | 6.15 |
| FY2019 | 58.7% | 14.68 |
| FY2018 | 44.1% | 19.24 |
| FY2017 | 24.8% | 16.11 |
| FY2016 | 8.70% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 58.5% | (1.14) |
| Jun 2026 | 59.6% | 1.43 |
| Mar 2026 | 58.2% | 0.05 |
| Dec 2025 | 58.1% | (0.69) |
| 31 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| INSP Inspire Medical Systems, Inc. compare | 86.2% |
| NVCR NovoCure Limited compare | 77.0% |
| AXGN AxoGen, Inc. compare | 74.2% |
| ESTA Establishment Labs Holdings Inc. compare | 70.5% |
| BFLY Butterfly Network, Inc. compare | 70.3% |
| TMDX TransMedics Group, Inc. | 58.6% |
| ALMR Alamar Biosciences, Inc. compare | 58.4% |
| NEOG Neogen Corporation compare | 47.4% |
| UFPT UFP Technologies, Inc. compare | 29.0% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on TMDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement